DTaP/Tdap/Td ACIP Vaccine Recommendations

Advisory Committee on Immunization Practices (ACIP)

Constrained U.S. Td supply, 2024

Production of one tetanus and diphtheria (Td) vaccine, TdVaxTM, has been discontinued. As a result, CDC anticipates that the supply of Td vaccine in the U.S. market will be constrained during 2024. CDC has developed guidance to help vaccination providers.

Read the guidance

Published in Morbidity and Mortality Weekly Report (MMWR)

The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).

CURRENT DTaP/Tdap/Td Vaccine Recommendations

See also:


ARCHIVED Historical DTaP/Tdap/Td Vaccine Recommendations

For your convenience, these archived publications can be used for historical and research purposes.


Adults (under 65 years old)

Adults 65 years and older

Infants and Young Children

Pregnancy Immunization